Passage Bio regains Nasdaq minimum bid price compliance

Passage BIO, Inc.

Received notice from Nasdaq on Feb 29, 2024 confirming compliance with Listing Rule 5450(a)(1).
Closing bid price of common stock was at least $1.00 for 10 consecutive business days through Feb 28.
Previously disclosed deficiency notice on Aug 31, 2023 for bid price below $1.00 for 30 days.
Listing matter is now closed; company meets all other continued listing criteria.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.